主要文件

查看所有文档

130249

2-硝基苯乙酸

Name: 2-硝基苯乙酸
Brand: ALDRICH

98%

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:

O₂NC₆H₄CH₂CO₂H

化学文摘社编号:

3740-52-1

分子量:

181.15

UNSPSC Code:

12352100

NACRES:

NA.22

PubChem Substance ID:

24847953

EC Number:

223-128-0

Beilstein/REAXYS Number:

1959243

MDL number:

MFCD00007190

Assay:

98%

Form:

solid

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

Quality Level

200

assay

98%

form

solid

mp

137-140 °C (lit.)

functional group

carboxylic acid, nitro

SMILES string

OC(=O)Cc1ccccc1[N+]([O-])=O

InChI

1S/C8H7NO4/c10-8(11)5-6-3-1-2-4-7(6)9(12)13/h1-4H,5H2,(H,10,11)

InChI key

WMUZDBZPDLHUMW-UHFFFAOYSA-N

说明

Application

2-Nitrophenylacetic acid was used as an internal standard in the determination of the theophylline solubilizer salicylamide-O-acetic acid.

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

法规信息

新产品

此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Leveraging a small-molecule modification to enable the photoactivation of rho GTPases.

Katryn R Harwood et al.

Chembiochem : a European journal of chemical biology, 10(18), 2855-2857 (2009-10-31)

Determination of the theophylline solubilizer salicylamide-O-acetic acid in serum and urine using high-performance liquid chromatography.

H U Schulz et al.

Journal of pharmaceutical and biomedical analysis, 3(5), 469-475 (1985-01-01)

A high-performance liquid chromatographic method for the determination of the theophylline solubilizer salicylamide-O-acetic acid has been developed in the range 0.5 to 10 microg/ml for human serum and 5 to 400 microg/ml for urine. Reversed-phase ion-pair chromatography was employed with

Comparison of activation of CPT-11 by rabbit and human carboxylesterases for use in enzyme/prodrug therapy.

M K Danks et al.

Clinical cancer research : an official journal of the American Association for Cancer Research, 5(4), 917-924 (1999-04-23)

Several recent studies have examined the possibility of producing tumor-specific cytotoxicity with various enzyme/ prodrug combinations. The enzymes are targeted to tumor cells either with antibodies (ADEPT, antibody directed enzyme prodrug therapy) or with viruses (VDEPT). The goal of the

查看所有相关文献

全球贸易项目编号

货号	GTIN
130249-25G	04061838727374
130249-100G	04061838345721